Cytotoxic Drugs in Steroid-Resistant Renal Disease

Warren E. Grupe

American journal of diseases of children · 1966 · 52 citations · 29 references

Concepts

Abstract

THE USE of cytotoxic agents in the treatment of renal diseases was first reported in 1949 by Chasis<sup>1,2</sup>using nitrogen mustard (mechlorethamine) in adults with chronic glomerulonephritis. Shortly thereafter, Kelley and Panos<sup>3</sup>confirmed improvement in children with nephrosis, and Taylor<sup>4</sup>in adults with chronic glomerulonephritis, using the same approach. These reports were followed by others,<sup>5-9</sup>but as the therapeutic value of steroids became more widely accepted, cytotoxic drugs were displaced as therapeutic agents. Interest was renewed in 1963 by Coldbeck,<sup>10</sup>Kellum and Haserick,<sup>11</sup>and Goodman and Wolff.<sup>12</sup>There has been further encouragement in the use of these agents in the treatment of other nonneoplastic diseases<sup>12-15</sup>as well as in renal diseases.<sup>15-22</sup> This report will review 3½ years' experience in 25 children with cytotoxic drugs in addition to corticosteroids in the treatment of chronic renal diseases. <h3>Patients and Methods</h3> The agents used

References

29